|
|
Thomson Financial Business Description:
| The Group's principal activities are the research and development of small molecule drugs which are being used to treat cancer. The Company operates within most areas of drug development, such as screening, medicinal chemistry, pre-clinical and clinical trials. The Group has operations in Denmark, Great Britain and Germany. The Group acquired G2M Cancer Drugs AG (now TopoTarget Germany AG) in Germany on the 25th of February 2005. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on TopoTarget A/S
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
